GlassScriptPhysician profile
Chad N Stasik
NPI 1164511200
$35,628.59
in general payments reported to CMS, 2019-2025
34 companies · $4,843 in 2025
The $4,843 reported for 2025 was more than what 82% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,169 · 2020: $6,322 · 2021: $4,767 · 2022: $3,702 · 2023: $4,689 · 2024: $4,136 · 2025: $4,843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $500 · Travel and Lodging: $486 · Education: $99.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,582.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $500.00 |
| Travel and Lodging | $486.10 |
| Education | $99.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $13,458.07 | 2019-2023 | Da Vinci Sp |
| Medtronic, INC. | $6,072.51 | 2021-2025 | Corevalve Evolut R, Avalus, Signia |
| Atricure, INC. | $3,882.39 | 2019-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System, Synergy Ablation System |
| Abbott Laboratories | $3,005.11 | 2019-2025 | Epic, Navitor |
| Abiomed | $2,942.95 | 2020-2025 | Impella |
| Medtronic Vascular, INC. | $1,168.99 | 2019-2020 | |
| Edwards Lifesciences Corporation | $951.20 | 2019-2025 | Sapien 3 Ultra Resilia |
| Corcym INC | $760.87 | 2022-2023 | Perceval |
| Getinge USA Sales, LLC | $588.01 | 2021-2025 | Vasoview Hemopro 2, Vasoview Hemopro 2 |
| Bolton Medical INC | $540.01 | 2020-2024 | Treo Abdominal Stent-Graft System |
| Baxter Healthcare | $277.60 | 2021-2025 | Perclot, Coseal, Preveleak |
| Astrazeneca Pharmaceuticals LP | $266.08 | 2022-2025 | Tagrisso |
| Clearflow INC. | $242.84 | 2025 | Pleuraflow System With Flowglide |
| Davol INC. | $236.43 | 2021-2025 | Progel Applicator Spray Tips |
| Kls-Martin L.P. | $231.47 | 2019-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $183.04 | 2019-2025 | Sternalock Blu System, Sternalock 360 System |
| Medical Device Business Services, INC. | $124.99 | 2024 | Ethicon |
| Lemaitre Vascular, INC. | $93.12 | 2025 | Cardiocel, Restoreflow |
| Janssen Pharmaceuticals, INC | $88.50 | 2019-2020 | |
| Boston Scientific Corporation | $57.99 | 2019 | |
| Chiesi USA, INC. | $57.97 | 2022-2024 | Cleviprex |
| Stryker Corporation | $57.96 | 2023 | Spy-Phi System |
| Z-Medica, LLC | $57.37 | 2019 | |
| Ethicon US, LLC | $48.10 | 2023 | Echelon Flex, Vistaseal |
| Lsi Solutions INC | $46.91 | 2022 | |
| Amgen INC. | $36.37 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.53 | 2019 | |
| Novartis Pharmaceuticals Corporation | $28.61 | 2019 | |
| Depuy Synthes Sales INC. | $21.97 | 2025 | Trumatch |
| Elite Orthopedics, LLC | $15.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.97 | 2019 | |
| W. L. Gore & Associates, INC. | $14.50 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $14.25 | 2019 | |
| Livanova USA, INC. | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Stasik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.